{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:48:36Z","timestamp":1788515316167,"version":"build-2803163510"},"reference-count":47,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1517\/14740330903439717","type":"journal-article","created":{"date-parts":[[2009,12,21]],"date-time":"2009-12-21T07:32:36Z","timestamp":1261380756000},"page":"167-176","source":"Crossref","is-referenced-by-count":40,"title":["Safety and tolerability of transdermal and oral rivastigmine in Alzheimer's disease and Parkinson's disease dementia"],"prefix":"10.1517","volume":"9","author":[{"given":"Taher","family":"Darreh-Shori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Jelic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2009,12,20]]},"reference":[{"key":"CIT0001","first-page":"S10","volume":"54","author":"Fratiglioni L","year":"2000","journal-title":"Neurology"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.6.730"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1177\/089198878800100106"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2005.11.039"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)91936-X"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-199912040-00005"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.59.4.563"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2009.01.050"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e3282f63f29"},{"key":"CIT0010","doi-asserted-by":"crossref","unstructured":"Darreh-Shori T, Modiri N, Nordberg A. ApoE and amyloid beta deflate the cholinergic transmission by boosting the activity and stability of cholinesterases in the brain. Poster presented at the International Conference on Alzheimer's Disease (ICAD), Vienna, Austria, 2009","DOI":"10.1016\/j.jalz.2009.04.463"},{"key":"CIT0011","doi-asserted-by":"crossref","unstructured":"Darreh-Shori T, Modiri N, Nordberg A. Apolipoprotein E and butyrylcholinesterase synergistically promote Ab peptides oligomerization. Poster presented at the International Conference on Alzheimer's Disease (ICAD), Vienna, Austria, 2009","DOI":"10.1016\/j.jalz.2009.04.169"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241100-00003"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100242"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1185\/030079908X253438"},{"key":"CIT0016","first-page":"109","volume":"8","author":"Anand R","year":"1996","journal-title":"J Drug Dev Clin Pract"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1177\/0091270006297748"},{"key":"CIT0018","first-page":"55","volume":"1","author":"Corey-Bloom J","year":"1998","journal-title":"Int J Geriatr Psychopharmacol"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7184.633"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2006.099424"},{"key":"CIT0021","first-page":"S26","volume":"1","author":"Schneider LS","year":"1998","journal-title":"Int J Geriatr Psychopharmacol"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041470"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1002\/gps.1788"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.3310\/hta10010"},{"key":"CIT0026","doi-asserted-by":"crossref","first-page":"451","DOI":"10.18553\/jmcp.2008.14.5.451","volume":"14","author":"Mucha L","year":"2008","journal-title":"J Manag Care Pharm"},{"key":"CIT0027","unstructured":"Nagy B, Brennan A, Brandtmuller A, The cost-utility of the rivastigmine transdermal patch in the management of patients with moderate Alzheimer's disease in the US. Poster presented at the annual meeting of the American Association for Geriatric Psychiatry (AAGP), Orlando, Florida, USA, 14\u201317 March, 2008"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2009.02052.x"},{"key":"CIT0031","unstructured":"Sadowsky C, Cummings J, Tekin S, Lane R. Achieving optimal therapeutic doses \u2013 rivastigmine (Exelon) patch and capsule. Poster presented at the 132nd Annual Meeting of the American Neurological Association (ANA), Washington, DC, USA, 7\u201310 October, 2007"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X162791"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0b013e31818b1c2c"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20700"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1159\/000008243"},{"key":"CIT0036","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2310\/6620.2008.07053","volume":"19","author":"Widman TJ","year":"2008","journal-title":"Dermatitis"},{"key":"CIT0037","unstructured":"Levin C, Maibach HI. Transdermal drug delivery system: an overview. In: Zhai, H Maibach, H editors, Marzulli and Maibach's Dermatotoxicology, 6th edition; Boca Raton, FL, 2008:101-6"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10586"},{"key":"CIT0039","unstructured":"Taylor P. Anticholinesterase agents. In: Goodman, AG Rall, TW Nies, ASTaylor, P editors, Goodman and Gilman's: The pharmacological basis of therapeutics, 8th edition; 1990"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1177\/00912700222011490"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000138500.73671.DC"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2006.00967.x"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200831010-00007"},{"key":"CIT0044","unstructured":"Lee J-H. Effects of body weight on tolerability of rivastigmine transdermal patch. Poster presented at the 24th Conference of Alzheimer's Disease International (ADI), Singapore, 2009"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1177\/0091270008330161"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1166(200003)15:3<242::AID-GPS110>3.0.CO;2-7"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-199813050-00005"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1002\/gps.1806"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1007\/s007020200089"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0602922103"},{"key":"CIT0052","unstructured":"Inestrosa NC, Alvarez A, Garrido J, Acetylcholinesterase promotes Alzheimer b-amyloid fibil formation. In: Iqbal K, Winblad B, Nishimura T, editors, Alzheimer's disease: biology, diagnosis and therapeutics. John Wiley & Sons Ltd; 1997"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14740330903439717","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T09:15:04Z","timestamp":1634375704000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14740330903439717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,20]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2009,12,11]]},"published-print":{"date-parts":[[2010,1]]}},"alternative-id":["10.1517\/14740330903439717"],"URL":"https:\/\/doi.org\/10.1517\/14740330903439717","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,20]]}}}